BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35684339)

  • 21. AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells.
    Rabi T; Huwiler A; Zangemeister-Wittke U
    Mol Carcinog; 2014 Jul; 53(7):578-88. PubMed ID: 23475563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells.
    Lewinska A; Adamczyk-Grochala J; Kwasniewicz E; Deregowska A; Wnuk M
    Apoptosis; 2017 Jun; 22(6):800-815. PubMed ID: 28213701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibiting autophagy increases epirubicin's cytotoxicity in breast cancer cells.
    Guo W; Wang Y; Wang Z; Wang YP; Zheng H
    Cancer Sci; 2016 Nov; 107(11):1610-1621. PubMed ID: 27560771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tea Polyphenol inhibits autophagy to sensitize Epirubicin-induced apoptosis in human bladder cancer cells.
    Gu W; Lin Y; Gou X; He W
    Neoplasma; 2017; 64(5):674-680. PubMed ID: 28592119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways.
    Wei T; Xiaojun X; Peilong C
    Biomed Pharmacother; 2020 Jan; 121():109139. PubMed ID: 31707337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
    Chen JM; Bai JY; Yang KX
    IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells.
    Xu J; Zuo D; Qi H; Shen Q; Bai Z; Han M; Li Z; Zhang W; Wu Y
    Biomed Pharmacother; 2016 Mar; 78():308-321. PubMed ID: 26898456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eriocalyxin B, a novel autophagy inducer, exerts anti-tumor activity through the suppression of Akt/mTOR/p70S6K signaling pathway in breast cancer.
    Zhou X; Yue GG; Chan AM; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Biochem Pharmacol; 2017 Oct; 142():58-70. PubMed ID: 28669564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methyl 3-hydroxyimino-11-oxoolean-12-en-28-oate (HIMOXOL), a synthetic oleanolic acid derivative, induces both apoptosis and autophagy in MDA-MB-231 breast cancer cells.
    Lisiak N; Paszel-Jaworska A; Bednarczyk-Cwynar B; Zaprutko L; Kaczmarek M; Rybczyńska M
    Chem Biol Interact; 2014 Feb; 208():47-57. PubMed ID: 24291674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical Evaluation of a Fluorine-18 (
    Altine B; Gai Y; Han N; Jiang Y; Ji H; Fang H; Niyonkuru A; Bakari KH; Rajab Arnous MM; Liu Q; Zhang Y; Lan X
    Mol Pharm; 2019 Nov; 16(11):4563-4571. PubMed ID: 31553879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ursolic acid promotes cancer cell death by inducing Atg5-dependent autophagy.
    Leng S; Hao Y; Du D; Xie S; Hong L; Gu H; Zhu X; Zhang J; Fan D; Kung HF
    Int J Cancer; 2013 Dec; 133(12):2781-90. PubMed ID: 23737395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory Effects of Ursolic Acid on the Stemness and Progression of Human Breast Cancer Cells by Modulating Argonaute-2.
    Liao WL; Liu YF; Ying TH; Shieh JC; Hung YT; Lee HJ; Shen CY; Cheng CW
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artesunate induces G2/M cell cycle arrest through autophagy induction in breast cancer cells.
    Chen K; Shou LM; Lin F; Duan WM; Wu MY; Xie X; Xie YF; Li W; Tao M
    Anticancer Drugs; 2014 Jul; 25(6):652-62. PubMed ID: 24518199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of α-enolase affects the biological activity of breast cancer cells by attenuating PI3K/Akt signaling pathway.
    Zang HY; Gong LG; Li SY; Hao JG
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):249-257. PubMed ID: 31957838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.
    Surmeli Z; Gursoy P; Erdogan AP; Bozkurt E; Atmaca H; Uzunoglu S; Sezgin C; Şanlı UA; Uslu R; Karaca B
    Tumour Biol; 2016 Mar; 37(3):3665-73. PubMed ID: 26462835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous proteasome and autophagy inhibition synergistically enhances cytotoxicity of doxorubicin in breast cancer cells.
    Loh JS; Rahim NA; Tor YS; Foo JB
    Cell Biochem Funct; 2022 Jun; 40(4):403-416. PubMed ID: 35485606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells.
    Ji Y; Di W; Yang Q; Lu Z; Cai W; Wu J
    Clin Lab; 2015; 61(8):1043-51. PubMed ID: 26427150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348/ATG7 axis.
    Wang Q; Liang D; Shen P; Yu Y; Yan Y; You W
    Transl Oncol; 2021 Aug; 14(8):101045. PubMed ID: 34023560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ampelopsin-induced autophagy protects breast cancer cells from apoptosis through Akt-mTOR pathway via endoplasmic reticulum stress.
    Zhou Y; Liang X; Chang H; Shu F; Wu Y; Zhang T; Fu Y; Zhang Q; Zhu JD; Mi M
    Cancer Sci; 2014 Oct; 105(10):1279-87. PubMed ID: 25088800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.